Scapular and Upper Limb Proprioceptive Neuromuscular Facilitation Techniques in Stroke With Scapular Dyskinesia.
Effects of Scapular and Upper Limb Proprioceptive Neuromuscular Facilitation Techniques on Shoulder Pain, Upper Limb Function & Gait in Stroke With Scapular Dyskinesia.
1 other identifier
interventional
44
1 country
2
Brief Summary
This study aims to fill this gap by investigating the effects of scapular and upper limb proprioceptive neuromuscular facilitation techniques on shoulder pain, upper limb function \& gait in stroke with scapular dyskinesia. This study is a randomized control trial that includes 44 patients which were randomly divided into two groups each containing 22 participants. Experimental group will receive scapular PNF coupled with upper limb PNF and conventional physiotherapy treatment and Control group will receive only Conventional treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2025
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 19, 2025
CompletedFirst Submitted
Initial submission to the registry
August 24, 2025
CompletedFirst Posted
Study publicly available on registry
August 29, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 20, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 21, 2026
CompletedAugust 29, 2025
August 1, 2025
5 months
August 24, 2025
August 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Fugl-Meyer Assessment of Upper Extremity (FMA-UE)
After a stroke, the FMA-UE is frequently used to evaluate and track recovery in hemiplegic patients.. It is a specific tool for quantifying upper limb impairment and rehabilitation outcomes in stroke patients with hemiparesis. Using a 3-point ordinal scale, the assessment rates the patient's ability to complete each task: 0 denotes incapacity to execute, 1 denotes partial completion, and 2 denotes full performance. All item scores, which range from 0 to 126, are added up to determine the final score.
6 weeks
Dynamic gait index (DGI)
A participant's ability to maintain walking balance while adjusting to different task demands and dynamic situations is evaluated by the Dynamic Gait Index (DGI). It is especially helpful for people who have balance and vestibular problems, as well as those who are at risk of falling. Every item has a rating between 0 and 3, where 0 denotes significant impairment and 3 denotes normal performance. 24 is the maximum possible score. A total score of less than 19 out of 24 indicates that older adults are more likely to fall, whereas a score of more than 22 indicates safe walking.
6 weeks
Visual Analogue Scale
Hayes and Patterson employed the visual analog scale (VAS), a pain rating tool, for the first time in 1921. A single handwritten mark is placed at one point along a 10-cm line that represents a continuum between the two ends of the scale, with "no pain" at the left end (0 cm) and the "worst pain" at the right end (10 cm). Self-identified evaluations of symptoms are used to calculate scores. The patient's discomfort is calculated by measuring the distance in centimeters between the patient's marks and the scale's beginning point (left end). The figures can be used to gauge a patient's pain progression or to compare pain across people with comparable diseases. 0 No pain, 1-3 slight pain, 4-6 moderate pain, and 7-10 excruciating pain.
6 weeks
10-Meter Walk Test (10MWT)
The test calculates walking speed over a brief distance in meters per second. To the closest tenth of a second, the total time spent walking six meters (m) is recorded. Then, 6 meters is divided by the whole time (in seconds) to convert this distance to m/s. The following categories apply to walking speeds: Family Ambulatory \<0.40 m/s; Community Ambulator ≥0.80 m/s; Limited Community Ambulator 0.40 to \<0.80 m/s
6 weeks
Study Arms (2)
GROUP 1
EXPERIMENTALscapular PNF coupled with upper limb PNF and conventional physiotherapy treatment.
GROUP 2
ACTIVE COMPARATORConventional treatment
Interventions
scapular PNF coupled with upper limb PNF and conventional physiotherapy treatment . It was a 6 week's intervention in which patients got treatment protocol for 30 mints 5 times a week.
Conventional treatment. It includes closed kinematic chain exercises of upper limb, upper and lower extremity range of motion exercises, stretching and strengthening exercises for upper limb, trunk and lower limb, balance \& coordination, manual dexterity exercises (e.g., grasp release), and teaching of ADLs.. It was a 6 week's intervention in which patients got treatment protocol for 30 mints 5 times a week.
Eligibility Criteria
You may qualify if:
- Sub-acute
- MCA
- Age bracket 40-65 years.
- Gender Male or Female.
- Gait baseline score (DGI less than 19)
- Patients with spasticity between grades (+1 and 1) on the Modified Ashworth Scale (MAS).
You may not qualify if:
- Inability to communicate/understand instructions.
- Stroke with other neurological conditions.
- Patient with any other psychological and medical condition.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
HBS Hospital islamabad
Islamabad, Punjab Province, 44000, Pakistan
National institute of rehablitation medicine islamabad
Islamabad, Punjab Province, 44000, Pakistan
Study Officials
- PRINCIPAL INVESTIGATOR
Mahat zafar, MSNMPT
Riphah International University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 24, 2025
First Posted
August 29, 2025
Study Start
August 19, 2025
Primary Completion
January 20, 2026
Study Completion
February 21, 2026
Last Updated
August 29, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share